CSB-111

Cytosite Biopharma Inc. · Phase 1 active Small molecule

At a glance

Generic name	CSB-111
Also known as	[68Ga]-NOTA-hGZP
Sponsor	Cytosite Biopharma Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CSB-111 CI brief — competitive landscape report
CSB-111 updates RSS · CI watch RSS
Cytosite Biopharma Inc. portfolio CI